Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Galactose can be an inducer for production of therapeutic proteins by auto-induction using E. coli BL21 strains.

Xu J, Banerjee A, Pan SH, Li ZJ.

Protein Expr Purif. 2012 May;83(1):30-6. doi: 10.1016/j.pep.2012.02.014. Epub 2012 Mar 8.

PMID:
22425658
2.

Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.

Panda AK.

Adv Biochem Eng Biotechnol. 2003;85:43-93. Review.

PMID:
12930093
3.

Human xanthine oxidase recombinant in E. coli: A whole cell catalyst for preparative drug metabolite synthesis.

Ferreira Antunes M, Eggimann FK, Kittelmann M, Lütz S, Hanlon SP, Wirz B, Bachler T, Winkler M.

J Biotechnol. 2016 Oct 10;235:3-10. doi: 10.1016/j.jbiotec.2016.03.045. Epub 2016 Mar 25. Review.

PMID:
27021957
4.
5.

Tunable recombinant protein expression in E. coli: promoter systems and genetic constraints.

Marschall L, Sagmeister P, Herwig C.

Appl Microbiol Biotechnol. 2017 Jan;101(2):501-512. doi: 10.1007/s00253-016-8045-z. Epub 2016 Dec 21. Review.

Supplemental Content

Support Center